MYC: connecting selective transcriptional control to global RNA production

Molecular Cell Biology

Lodish, H. F. (1986) · Cited by 5,650

Identification of c- MYC as a Target of the APC Pathway

He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566

MYC on the Path to Cancer

Dang, C. V. (2012) · Cell · doi:10.1016/j.cell.2012.03.003 · Cited by 3,390

CpG islands and the regulation of transcription

Deaton, A. M., & Bird, A. (2011) · Genes & Development · doi:10.1101/gad.2037511 · Cited by 3,187

Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804

Stat3 as an Oncogene

Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790

The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation

Wang, R., Dillon, C. P., Shi, L. Z., Milasta, S., Carter, R., Finkelstein, D., McCormick, L. L., Fitzgerald, P., Chi, H., Munger, J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.021 · Cited by 2,140

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism

Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124

Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction

Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001

WNT Oncogenic Transcription Requires MYC Suppression of Lysosomal Activity and EPCAM Stabilization in Gastric Tumors

Mulé, P., Fernández-Pérez, D., Amato, S., Manganaro, D., Oldani, P., Brandini, S., Diaferia, G. R., Cuomo, A., Recordati, C., Soriani, C., et al. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.06.029 · Cited by 12

Splicing and Dicing MYC-Mediated Synthetic Lethality

Stine, Z. E., & Dang, C. V. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.016 · Cited by 12

A circular RNA, circPTPN14, increases MYC transcription by interacting with FUBP1 and exacerbates renal fibrosis

Nie, W., Li, M., Liu, B., Zhang, Y., Wang, Y., Wang, J., Jin, L., Ni, A., Xiao, L., Shen, X. Z., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04603-9 · Cited by 11

Synthetic molecules for disruption of the MYC protein-protein interface

Jacob, N. T., Miranda, P. O., Shirey, R. J., Gautam, R., Zhou, B., de Orbe, M. E., Hixon, M. S., Hart, J. R., Ueno, L. A., Vogt, P. K., et al. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.07.019 · Cited by 12

TEAD activity is restrained by MYC and stratifies human breast cancer subtypes

Elster, D., Jaenicke, L. A., Eilers, M., & von Eyß, B. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1207837 · Cited by 11

Sulfinyl Aziridines as Stereoselective Covalent Destabilizing Degraders of the Oncogenic Transcription Factor MYC

Rosen, H. T., Li, K., Stieger, C. E., Li, E. L., Currier, B., Brittain, S. M., Garcia, F. J., Beard, D. C., Jones, M. D., Haenni‐Holzinger, S., et al. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202508518 · Cited by 15

Identification of antimycin A as a c-Myc degradation accelerator via high-throughput screening

Liu, Z., Ishikawa, K., Sanada, E., Semba, K., Li, J., Li, X., Osada, H., & Watanabe, N. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105083 · Cited by 11

A competitive precision CRISPR method to identify the fitness effects of transcription factor binding sites

Pihlajamaa, P., Kauko, O., Sahu, B., Kivioja, T., & Taipale, J. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01444-6 · Cited by 11

Transcriptional regulation of MYC through G-quadruplex structures

Balaratnam, S., & Schneekloth, J. S. (2020) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2020.05.002 · Cited by 12

Construction of a circRNA-miRNA-mRNA Regulatory Network Reveals Potential Mechanism and Treatment Options for Osteosarcoma

He, Y., Zhou, H., Wang, W., Xu, H., & Cheng, H. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.632359 · Cited by 11

MYC directly transactivates CR2/CD21, the receptor of the Epstein–Barr virus, enhancing the viral infection of Burkitt lymphoma cells

Molina, E., García-Gutiérrez, L., Junco, V., Pérez‐Olivares, M., de Yébenes, V. G., Blanco, R. E., Quevedo, L., Acosta, J. C., Marín, A. V., Ulgiati, D., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02846-9 · Cited by 10

Immune control in acute myeloid leukemia

Straube, J., Janardhanan, Y., Haldar, R., & Bywater, M. J. (2024) · Experimental Hematology · doi:10.1016/j.exphem.2024.104256 · Cited by 11

Senataxin prevents replicative stress induced by the Myc oncogene

Sberna, S., Filipuzzi, M., Bianchi, N., Croci, O., Fardella, F., Soriani, C., Rohban, S., Carnevali, S., Albertini, A. A., Crosetto, N., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07485-4 · Cited by 9

Metabolic rewiring in MYC-driven medulloblastoma by BET-bromodomain inhibition

Graziani, V., Rodriguez‐Garcia, A., Sainero‐Alcolado, L., Guennec, A. D. L., Arsenian‐Henriksson, M., & Conte, M. R. (2023) · Scientific Reports · doi:10.1038/s41598-023-27375-z · Cited by 10

Oncogenic signaling pathways in pancreatic ductal adenocarcinoma

Agrawal, R., & Natarajan, K. N. (2023) · Advances in cancer research · doi:10.1016/bs.acr.2023.02.006 · Cited by 10

Measuring MYC-Mediated Metabolism in Tumorigenesis

Tang, H., Goldman, A. R., Zhang, X., Speicher, D. W., & Dang, C. V. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1476-1_11 · Cited by 10

Imaging-Based Screening of Deubiquitinating Proteases Identifies Otubain-1 as a Stabilizer of c-MYC

Moree, S. E., Maneix, L., Iakova, P. A., Stossi, F., Sahin, E., & Catic, A. (2022) · Cancers · doi:10.3390/cancers14030806 · Cited by 10

Leg length and bristle density, both necessary for water surface locomotion, are genetically correlated in water striders

Finet, C., Decaras, A., Rutkowska, M., Roux, P., Collaudin, S., Joncour, P., Viala, S., & Khila, A. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119210119 · Cited by 10

The establishment of a growth-controllable orthotopic bladder cancer model through the down-regulation of c-myc expression

Seo, H. K., Shin, S.-P., Jung, N., Kwon, W., Jeong, K., & Lee, S.-J. (2016) · Oncotarget · doi:10.18632/oncotarget.10784 · Cited by 10

ZFP281 Recruits MYC to Active Promoters in Regulating Transcriptional Initiation and Elongation

Luo, Z., Liu, X., Xie, H., Wang, Y., & Lin, C. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00329-19 · Cited by 10

The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and induces tumorigenic properties

Hoesl, C., Zanuttigh, E., Fröhlich, T., Philippou‐Massier, J., Krebs, S., Blum, H., & Dahlhoff, M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118717 · Cited by 10

Shared molecular, cellular, and environmental hallmarks in cardiovascular disease and cancer: Any place for drug repurposing?

Avolio, E., Bassani, B., Campanile, M., Mohammed, K. A. K., Muti, P. C., Bruno, A., Spinetti, G., & Madeddu, P. R. (2024) · Pharmacological Reviews · doi:10.1016/j.pharmr.2024.100033 · Cited by 9

CircPVT1 Promotes Lung Metastasis and Tumor Progression in Renal Cell Carcinoma by Encoding the cP104aa Peptide and Targeting EIF4A3

Zhang, H., Tao, T., Ji, J., Zhao, T., Sun, S., Zhang, L., Wu, J., Chen, M., Chen, S., Xu, B., et al. (2025) · Advanced Science · doi:10.1002/advs.202501211 · Cited by 9

The maternal‐zygotic transition and zygotic activation of the Mnemiopsis leidyi genome occurs within the first three cleavage cycles

Davidson, P. L., Koch, B. J., Schnitzler, C. E., Henry, J. J., Martindale, M. Q., Baxevanis, A. D., & Browne, W. E. (2017) · Molecular Reproduction and Development · doi:10.1002/mrd.22926 · Cited by 9

Differential effects of Vav‐promoter‐driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesis

Tuzlak, S., Haschka, M. D., Mokina, A. M., Rülicke, T., Cory, S., Labi, V., & Villunger, A. (2018) · FEBS Journal · doi:10.1111/febs.14426 · Cited by 9

Feedforward regulation of Myc coordinates lineage-specific with housekeeping gene expression during B cell progenitor cell differentiation

Ferreirós-Vidal, I., Carroll, T., Zhang, T., Lagani, V., Ramírez, R. N., Ing‐Simmons, E., Gómez-Valadés, A. G., Cooper, L., Liang, Z., Παπουτσόγλου, Γ., et al. (2019) · PLoS Biology · doi:10.1371/journal.pbio.2006506 · Cited by 9

The transcriptional stress response and its implications in cancer treatment

Cruz-Ruiz, S., Urióstegui-Arcos, M., & Zurita, M. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188620 · Cited by 9

High Expression of PAMR1 Predicts Favorable Prognosis and Inhibits Proliferation, Invasion, and Migration in Cervical Cancer

Yang, R., Ma, M., Yu, S., Li, X., Zhang, J., & Wu, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.742017 · Cited by 9

Lysine-52 stabilizes the MYC oncoprotein through an SCFFbxw7-independent mechanism

Melo, J. D., Kim, S. S., Lourenco, C., & Penn, L. Z. (2017) · Oncogene · doi:10.1038/onc.2017.268 · Cited by 10

MYC promotes immune-suppression in TNBC via inhibition of IFN signalingPreprint

Zimmerli, D., Brambillasca, C. S., Talens, F., Bhin, J., Bhattacharya, A., Joosten, S. E. P., Silva, A. M. D., Wellenstein, M. D., Kersten, K., de Boo, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.24.432659 · Cited by 9

FBXO8 is a novel prognostic biomarker in different molecular subtypes of breast cancer and suppresses breast cancer progression by targeting c-MYC

Khan, A. J., Man, S., Abbas, M., Liu, S., & Zhang, F. (2024) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2024.130577 · Cited by 8

Implications of c-Myc in the pathogenesis and treatment efficacy of urological cancers

Hushmandi, K., Saadat, S. H., Raei, M., Daneshi, S., Aref, A. R., Nabavi, N., Taheriazam, A., & Hashemi, M. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155381 · Cited by 8

Targeting MYCN upregulates L1CAM tumor antigen in MYCN-dysregulated neuroblastoma to increase CAR T cell efficacy

Grunewald, L., Andersch, L., Helmsauer, K., Schwiebert, S., Klaus, A., Henssen, A. G., Straka, T., Lodrini, M., Wicha, S. G., Fuchs, S., et al. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107608 · Cited by 8

Selective Enhancer Dependencies in MYC -Intact and MYC -Rearranged Germinal Center B-cell Diffuse Large B-cell Lymphoma

Iyer, A. R., Gurumurthy, A., Chu, A., Kodgule, R., Aguilar, A. R., Saari, T. W., Ramzan, A., Rosa, J., Gupta, J., Emmanuel, A., et al. (2025) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-24-0126 · Cited by 9

MYC controls STING levels to downregulate inflammatory signaling in breast cancer cells upon DNA damage

Linstra, R., Stappenbelt, C., Bakker, F. J., Everts, M., Bhattacharya, A., Yu, S., van Bergen, S. D., van der Vegt, B., Wisman, G. B. A., Fehrmann, R. S. N., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108560 · Cited by 8

Targeting SUMOylation in ovarian cancer: Sensitivity, resistance, and the role of MYC

Littler, S., Barnes, B. M., Owen, R., Nelson, L., Tighe, A., Lin, I., Osborne, H. C., Schmidt, C. K., McGrail, J. C., & Taylor, S. S. (2025) · iScience · doi:10.1016/j.isci.2025.112555 · Cited by 8

Molecular regulation and therapeutic targeting of MYCN in neuroblastoma: a comprehensive review

Chen, Y., Yang, H., Xiao, L., Yan, N., & Zhang, M. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1683331 · Cited by 9

MXD/MIZ1 transcription regulatory complexes activate the expression of MYC‐repressed genes

Shostak, A., Schermann, G., Diernfellner, A. C. R., & Brunner, M. (2021) · FEBS Letters · doi:10.1002/1873-3468.14097 · Cited by 8

MYC promotes global transcription in part by controlling P-TEFb complex formation via DNA-binding independent inhibition of CDK9 SUMOylation

Guan, Q., Chen, Z., Yu, F., Liu, L., Huang, Y., Wei, G., Chiang, C., Wong, J., & Li, J. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2281-6 · Cited by 9

Acetylcorynoline Induces Apoptosis and G2/M Phase Arrest through the c-Myc Signaling Pathway in Colon Cancer Cells

Park, Y.-R., Jee, W., Park, S.-M., Kim, S. W., Jung, J. H., Kim, H., Kim, K., & Jang, H.-J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417589 · Cited by 8

The MYC-Regulated RNA-Binding Proteins hnRNPC and LARP1 Are Drivers of Multiple Myeloma Cell Growth and Disease Progression and Negatively Predict Patient Survival

Seibert, M., Koschade, S. E., Stolp, V., Häupl, B., Wempe, F., Serve, H. L., Kurrle, N., Schnütgen, F., & von Metzler, I. (2023) · Cancers · doi:10.3390/cancers15235508 · Cited by 7

Cell competition eliminates aneuploid human pluripotent stem cells

Ya, A., Deng, C., & Godek, K. M. (2025) · Stem Cell Reports · doi:10.1016/j.stemcr.2025.102506 · Cited by 7

Development, anti-proliferative activity, multi-target kinase inhibition against CHK1, PIM1, and CDK-2, and computational insights of new thiazole-based hybrids

Altwaijry, N., Othman, I. M. M., Anwar, M. M., Nosier, S. S., Saleh, A., Tashkandi, N. Y., & Nossier, E. S. (2026) · RSC Advances · doi:10.1039/d6ra00253f · Cited by 7

Targeting oncoproteins for degradation by small molecules in myeloid leukemia

Lei, H., Wang, W., & Wu, Y. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1403600 · Cited by 7

Construction of a Novel MYC-Associated ceRNA Regulatory Network to Identify Prognostic Biomarkers in Colon Adenocarcinoma

Xin, R., Tang, X.-M., Jiang, Y., Yu, F., Li, S., Jia, C., Wang, G., Fu, D., Liu, J.-B., & Ma, Y. (2022) · Journal of Oncology · doi:10.1155/2022/3216285 · Cited by 7

AGAP2-AS1/BRD7/c-Myc signaling axis promotes skin cutaneous melanoma progression.

Wu, L., Li, S., Xu, J., Shen, C., & Qian, Q. (2023) · PubMed Central · Cited by 7

MYC Up-regulation Is a Useful Biomarker for Preoperative Neoadjuvant Chemotherapy Combined With Anti-EGFR in Liver Metastasis from Colorectal Cancer

Kato, T., Matsuhashi, N., Tomita, H., Takahashi, T., IWATA, Y., Fukada, M., Yasufuku, I., Suetsugu, T., Imai, T., Mori, R., et al. (2021) · In Vivo · doi:10.21873/invivo.12249 · Cited by 7

Loss of PABPC1 is compensated by elevated PABPC4 and correlates with transcriptome changesPreprint

Xie, J., Wei, X., & Chen, Y. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.07.430165 · Cited by 7

The transcriptome of HTLV-1-infected primary cells following reactivation reveals changes to host gene expression central to the proviral life cycle

Aristodemou, A., Rueda, D., Taylor, G. P., & Bangham, C. R. M. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011494 · Cited by 6

JS-K induces ferroptosis in renal carcinoma cells by regulating the c-Myc-GSTP1 Axis

Zhao, Y., Zhu, L., Lin, X., Li, B., Miu, B., Qiu, J., Gao, S., & Liu, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-97887-3 · Cited by 6

Benzofuranyl-pyrazole as a Novel Scaffold for In Vitro and In Vivo Potent Anticancer Therapeutics That Directly Disrupt the ‘Undruggable’ MYC Oncogene and Potentiate Immune Checkpoint Blockage

Yang, L., Zuo, H., Sha, M., Zhan, W., Li, J., Liu, Y., Fang, F., Wang, Y., & Ma, X. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01307 · Cited by 6

Pneumococcal H₂O₂ reshapes mitochondrial function and reprograms host cell metabolism

Scasny, A., Alibayov, B., Hoang, N., Vidal, A. G. J., Takeshita, K., Bautista-Muñoz, C. D. C., Bengtén, E., Baez, A., Li, W., Hosler, J. P., et al. (2025) · mBio · doi:10.1128/mbio.02019-25 · Cited by 8

The Interplay Between the MYC Oncogene and Ribosomal Proteins in Osteosarcoma Onset and Progression: Potential Mechanisms and Indication of Candidate Therapeutic Targets

Guerrieri, A. N., Hattinger, C. M., Marchesini, F., Melloni, M., Serra, M., Ibrahim, T., & Penzo, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212031 · Cited by 6

Changes in AXL and/or MITF melanoma subpopulations in patients receiving immunotherapy

Willemsen, M., Bulgarelli, J., Chauhan, S. K., Lereim, R. R., Angeli, D., Grisendi, G., Krebbers, G., Davidson, I., Kyte, J. A., Guidoboni, M., et al. (2024) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2024.101009 · Cited by 7

MicroRNAs of miR-17-92 cluster increase gene expression by targeting mRNA-destabilization pathways

Jung, E., Seong, Y., Jeon, B., Kwon, Y.-S., & Song, H. (2018) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2018.06.003 · Cited by 6

Differentiation of imatinib -resistant chronic myeloid leukemia cells with BCR-ABL-T315I mutation induced by Jiyuan Oridonin A

Xu, Y. F., Wang, Z., Zhang, L., Gao, C., Li, F., Li, X., Ke, Y., Liu, H., Hu, Z., Wei, L., et al. (2023) · Journal of Cancer · doi:10.7150/jca.83219 · Cited by 7

Emerging Roles of Signal Transduction Pathways in Neurodegenerative Diseases. Hunting New Possible Therapeutic Molecular Targets

Vasco, V. R. L. (2023) · OBM Geriatrics · doi:10.21926/obm.geriatr.2302234 · Cited by 6

c-Myc inhibits LAPTM5 expression in B-cell lymphomas

Zhang, Y., Zhang, X., Zhang, Y., Han, X., Wei, Z., Wang, X., Li, Y., Guo, J., Wu, F., Fang, X., et al. (2023) · Annals of Hematology · doi:10.1007/s00277-023-05434-9 · Cited by 6

Combination immuno-oncology therapy with immune checkpoint blockers targeting PD-L1, PD-1 or CTLA4 and epigenetic drugs targeting MYC and immune evasion for precision medicine

Katoh, M. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.03.62 · Cited by 6

NF-κB-dependent Mechanism of Action of c-Myc Inhibitor 10058-F4: Highlighting a Promising Effect of c-Myc Inhibition in Leukemia Cells, Irrespective of p53 Status.

Sayyadi, M., Safaroghli‐Azar, A., Safa, M., Abolghasemi, H., Momeny, M., & Bashash, D. (2020) · PubMed Central · doi:10.22037/ijpr.2020.112926.14018 · Cited by 6

Rapid-kinetics degron benchmarking reveals off-target activities and mixed agonism-antagonism of MYB inhibitorsPreprint

Harada, T., Perez, M. W., Kalfon, J., Braes, F. D., Batley, R., Eagle, K., Nabet, B., Leifer, B. S., Kruell, J. A., Paralkar, V. R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.07.536032 · Cited by 6

ADAMTS4 exacerbates lung cancer progression via regulating c-Myc protein stability and activating MAPK signaling pathway

Zhai, W., Yang, W., Ge, J., Xiao, X., Wu, K., She, K., Zhou, Y., Kong, Y., Wu, L., Luo, S., et al. (2024) · Biology Direct · doi:10.1186/s13062-024-00512-y · Cited by 5

Targeting processive transcription for Myc-driven circuitry in medulloblastoma

Sobral, L. M., Walker, F. M., Madhavan, K. P. C., Janko, E., Donthula, S., Danis, E. P., Bompada, P., Balakrishnan, I., Wang, D., Pierce, A. M., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf121 · Cited by 5

Co-expression patterns explain how a basic transcriptional role for MYC modulates Wnt and MAPK pathways in colon and lung adenocarcinomas

Kucherlapati, M. H. (2022) · Cell Cycle · doi:10.1080/15384101.2022.2060454 · Cited by 5

A New Insight into MYC Action: Control of RNA Polymerase II Methylation and Transcription Termination

Scagnoli, F., Palma, A., Favia, A., Scuoppo, C., Illi, B., & Nasi, S. (2023) · Biomedicines · doi:10.3390/biomedicines11020412 · Cited by 5

Translocation Tales: Unraveling the MYC Deregulation in Burkitt Lymphoma for Innovative Therapeutic Strategies

Tandon, A., Kuriappan, J. A., & Dubey, V. (2023) · Lymphatics · doi:10.3390/lymphatics1020010 · Cited by 5

FABP6 serves as a new therapeutic target in esophageal tumor

Zhang, D., Zhao, F., Liu, H., Guo, P., Li, Z., & Li, S. (2024) · Aging · doi:10.18632/aging.205448 · Cited by 5

Control of Cell Division

Fischer, M., Dang, C. V., & DeCaprio, J. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00017-2 · Cited by 7

N -myristoyltransferase inhibition is synthetic lethal in MYC-deregulated cancersPreprint

Lueg, G. A., Faronato, M., Gorelik, A., Grocin, A. G., Caamaño‐Gutiérrez, E., Francesco Falciani, B., Solari, R. C. E., Carr, R. A. E., Bell, A., Bartlett, E. J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.20.436222 · Cited by 6

Author response: Association with TFIIIC limits MYCN localization in hubs of active promoters and chromatin accumulation of non-phosphorylated RNA Polymerase II

Vidal, R. S., Leen, E. N., Herold, S., Müller, M., Fleischhauer, D., Schülein‐Völk, C., Papadopoulos, D., Röschert, I., Uhl, L., Ade, C. P., et al. (2024) · eLife · doi:10.7554/elife.94407.2.sa0 · Cited by 4

Reviewer #3 (Public Review): Association with TFIIIC limits MYCN localization in hubs of active promoters and chromatin accumulation of non-phosphorylated RNA Polymerase II

Vidal, R., Leen, E. N., Herold, S., et al. (2024) · eLife · doi:10.7554/elife.94407.2.sa1 · Cited by 4

Beyond the Limit: MYC Mediates Tumor Immune Escape

Hong, Z., Ming, S., Luan, X., Sun, Z., & Zhang, W. (2025) · Pharmaceuticals · doi:10.3390/ph18070978 · Cited by 4

Targeting miR-32-5p suppresses c-MYC-driven proliferation and induces apoptosis in MCF-7 breast cancer cells

Khoder, A. I., El-Sayed, I. H., & Ali, Y. B. M. (2025) · Medical Oncology · doi:10.1007/s12032-025-02935-7 · Cited by 4

Transcriptomic Comparisons of Somatic and Cancer Stem Cells

Drysch, A. P., Ahuja, A., Prasad, D., Jain, R., Romanos, S. G., Alwakeal, A., & Ahuja, C. S. (2025) · Biomedicines · doi:10.3390/biomedicines13082039 · Cited by 6

Lysosome‐Mediated Targeted Protein Degradation: Emerging Chimeric Platforms for Extracellular and Intracellular Therapeutics

Asadi, S., Taheri‐Torbati, M., Kesharwani, P., & Sahebkar, A. (2025) · Drug Development Research · doi:10.1002/ddr.70197 · Cited by 4

Lethal co-expression intolerance underlies the mutually exclusive expression of ASCL1 and NEUROD1 in SCLC cells

Watanabe, H., Inoue, Y., Tsuchiya, K., Asada, K., Suzuki, M., Ogawa, H., Tanahashi, M., Watanabe, T., Matsuura, S., Yasuda, K., et al. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00860-6 · Cited by 4

The Role of the Hexosamine-Sialic Acid Metabolic Pathway Mediated by GFPT1/NANS in c-Myc-Driven Hepatocellular Carcinoma

Wang, S., Han, P., Mi, P., Wang, C., Lu, M., Li, X., Xu, B., Wang, H., Gao, Y., Hou, Y., et al. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101523 · Cited by 4

Association with TFIIIC limits MYCN localisation in hubs of active promoters and chromatin accumulation of non-phosphorylated RNA polymerase II

Vidal, R. S., Leen, E. N., Herold, S., Müller, M., Fleischhauer, D., Schülein‐Völk, C., Papadopoulos, D., Röschert, I., Uhl, L., Ade, C. P., et al. (2024) · eLife · doi:10.7554/elife.94407 · Cited by 4

Tissue-specific adaptations to cytochrome c oxidase deficiency shape physiological outcomes

Popović, M., Isermann, L., Geißen, S., Senft, K., Georgomanolis, T., Baldus, S. E., Frezza, C., & Trifunović, A. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167567 · Cited by 4

MNT suppresses T cell apoptosis via BIM and is critical for T lymphomagenesis

Nguyen, H. V., Vandenberg, C. J., Robati, M., Ng, A. P., & Cory, S. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01119-y · Cited by 5

Polycomb group ring finger protein 6 suppresses Myc-induced lymphomagenesis

Tanasković, N., Dalsass, M., Ceccotti, G., Filipuzzi, M., Verrecchia, A., Nicoli, P., Doni, M., Olivero, D., Pasini, D., Koseki, H., et al. (2022) · Life Science Alliance · doi:10.26508/lsa.202101344 · Cited by 4

CDK2 inhibition promotes neuronal differentiation in neuroblastoma

Alzrigat, M., Mahmoud, L., Topçu, A. N., Valenti, M., Zhang, L., Veen, P., John, F. C., Bazzar, W., Lehti, K., & Larsson, L.-G. (2026) · Scientific Reports · doi:10.1038/s41598-026-38123-4 · Cited by 3

Integration of signaling pathway and bromodomain and extra-terminal domain inhibition for the treatment of mutant Kirsten rat sarcoma viral oncogene homolog cancer

Hamilton, G., Stickler, S., & Rath, B. (2023) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2023.00178 · Cited by 3

Myc 9aaTAD activation domain binds to mediator of transcription with superior high affinity

Knight, A., Houser, J., Otaševič, T., Juráň, V., Vybíhal, V., Smrčka, M., & Piskáček, M. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00896-7 · Cited by 3

Prognostic Value of the G2 Expression Signature and MYC Overexpression in Childhood High-Grade Osteosarcoma

van Ewijk, R., Hiemcke‐Jiwa, L. S., Hehir‐Kwa, J. Y., Gaspar, N., Haveman, L., Flucke, U. E., Dandis, R., van Tuil, M. C., Janda, C. Y., van de Sande, M. A. J., et al. (2025) · JCO Precision Oncology · doi:10.1200/po-24-00855 · Cited by 4

Ontogeny, Genetics, Molecular Biology, and Classification of B- and T-Cell Non-Hodgkin Lymphoma

Ryan, R. J. H., & Wilcox, R. A. (2019) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2019.04.003 · Cited by 3

De Novo Palmitate Synthesis Supports Oncogenic Signalling and Tumor Growth Through Diverse Mechanisms: Implications for FASN-Targeted Therapeutics

Heuer, T. S. (2016) · Journal of Cell Signaling · doi:10.4172/2576-1471.1000124 · Cited by 3

FC1000: normalized gene expression changes of systematically perturbed human cells

Lönnstedt, I. M., & Nelander, S. (2017) · Statistical Applications in Genetics and Molecular Biology · doi:10.1515/sagmb-2016-0072 · Cited by 3

The landscape of S100B+ and HLA-DR+ dendritic cell subsets in tonsils at the single cell level via high-parameter mappingPreprint

Bolognesi, M. M., Bosisio, F. M., Manzoni, M., Schapiro, D., Tagliabue, R., Faretta, M., Parravicini, C., Haberman, A. M., & Cattoretti, G. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/369983 · Cited by 4

Specificity of anti-MYC antibodies

Cattoretti, G. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.l119.011910 · Cited by 3

The multi-faceted roles of MYC in the prognosis of chronic lymphocytic leukemia

Ysebaert, L., Mouchel, P., Laurent, C., & Quillet‐Mary, A. (2025) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2024.2447362 · Cited by 2

Enforced MYC expression directs a distinct transcriptional state during plasma cell differentiation

Vardaka, P., Kemp, B., Stephenson, S., Stephenson, S., Care, M. A., Umpierrez, M., O'Callaghan, E., O’Callaghan, E., Owen, R. G., Hodson, D. J., et al. (2025) · Life Science Alliance · doi:10.26508/lsa.202402814 · Cited by 6

MNT: a new target for AML

Fischer, K. C., Litalien, V., Diepstraten, S. T., Jahja, M., Brown, F. C., Kelly, G. L., Wei, A. H., & Cory, S. (2025) · Blood Neoplasia · doi:10.1016/j.bneo.2025.100149 · Cited by 2

Diverse oncogenes use common mechanisms to drive growth of major forms of human cancer

Kauko, O., Turunen, M. M., Pihlajamaa, P., Häkkinen, A., Queiroz, R. M. L., Pääkkönen, M., Ventelä, S., Gaetani, M., Lundström, S. L., Murgia, A., et al. (2025) · Science Advances · doi:10.1126/sciadv.adt1798 · Cited by 2

Combined MYC Activation and PTEN Loss Drives Molecular Features of Aggressive Preinvasive Lesions in Mouse Prostate

Rubenstein, M., Rege, A., Hubbard, G. K., Cannady, D., Agarwal, S., Chen, K. Z., Estrada, A., Gomes-Alexandre, C., Hicks, J. L., Jones, T., et al. (2025) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-24-1206 · Cited by 2

A combined study of network-based prediction and in vitro experimental validation on the procarcinogenic mechanism of propylparaben in estrogen receptor-positive breast cancer cells

Wen, J., Liang, Y., Mo, L., Sun, W., Qin, Y., Yue, H., & Zhu, H. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.119504 · Cited by 2

LAT1 / SLC7A5 ‐mediated amino acid uptake is regulated by redox signals triggered by formyl‐peptide receptor 2

Cassese, M., Brignola, C., Marrone, S., Esposito, G., Ammendola, R., & Cattaneo, F. (2025) · FEBS Journal · doi:10.1111/febs.70370 · Cited by 2

Association between genetic variations at 8q24 and prostate cancer risk in Mexican Men

Silva-Ramírez, B., Macías-González, E. J., Frausto-Valdes, O. S., Calao-Pérez, M. B., Ibarra-Pérez, D. I., Torres-García, J. E., Aragón-Tovar, A., Peñuelas-Urquides, K., González-Escalante, L. A., & de León, M. B. (2021) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-021-00461-x · Cited by 2

Per- and Polyfluoroalkyl Substances Disrupt Mouse Embryo Compaction by Targeting c-MYC

Liu, Y., Jiang, X., Xu, C., Xu, Y., Zhang, C., Xu, J., & Hu, J. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c06532 · Cited by 2

Mammalian Proteome Profiling Reveals Readers and Antireaders of Strand‐Symmetric and ‐Asymmetric 5‐Hydroxymethylcytosine‐Modifications in DNA

Engelhard, L., Cakil, Z. V., Zambrano-Mila, M. S., Eppmann, S., Gonzalez, T. I., Linser, R., Janning, P., Becker, S. M., & Summerer, D. (2026) · Advanced Science · doi:10.1002/advs.202511925 · Cited by 2

Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis

Sabò, A., Kress, T. R., Pelizzola, M., de Pretis, S., Gorski, M. M., Tesi, A., Morelli, M. J., Bora, P., Doni, M., Verrecchia, A., et al. (2014) · Nature · doi:10.1038/nature13537 · Cited by 496

Fine-tuned amplification in cells

Dang, C. V. (2014) · Nature · doi:10.1038/nature13518 · Cited by 29

MYC function and regulation in physiological perspective

Jha, R., Kouzine, F., & Levens, D. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1268275 · Cited by 107

Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles

Walz, S., Lorenzin, F., Morton, J. P., Wiese, K. E., von Eyß, B., Herold, S., Rycak, L., Dumay‐Odelot, H., Karim, S. A., Bartkuhn, M., et al. (2014) · Nature · doi:10.1038/nature13473 · Cited by 502

Measuring MYC-Mediated Metabolism in Tumorigenesis

Tang, H., Goldman, A. R., Zhang, X., Speicher, D. W., & Dang, C. V. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1476-1_11 · Cited by 10